AC 591
Alternative Names: AC-591Latest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Shandong New Time Pharmaceutical Co LTD
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Peripheral neuropathies
Most Recent Events
- 09 Dec 2024 Preclinical trials in Peripheral neuropathies (Prevention) in China (PO) before December 2024
- 09 Dec 2024 Shandong New Time Pharmaceutical plans a phase II trial for Peripheral neuropathy (Prevention) (PO) in December 2024 (NCT06722950)